Recent Finacing
Recent Raise
Neurenati Therapeutics develops NEU-001, an intrarectal growth-factor therapy to regenerate enteric neurons and restore motility in newborns with Hirschsprung disease, conducting IND-enabling studies and cGMP production.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
